Concord Biotech approves first-ever 1:1 bonus issue
In short
Concord Biotech’s board approved a first-ever 1:1 bonus issue on September 23. The stock rose nearly 2% after the news.
The move may reward shareholders with extra shares, but the record date was not stated. It is also not stated how many bonus shares will be issued in total.
What the reporting says
Concord Biotech Limited approved its first-ever 1:1 bonus issue on September 23, according to a publisher-supplied summary. The stock rose nearly 2% after the announcement, showing some investor interest. The reporting does not state the record date or how many shares will be issued.
Why it matters
Concord Biotech Limited announced and board-approved its first-ever 1:1 bonus issue on September 23. The stock moved up nearly 2% after the announcement, according to the summary. The reporting does not state the record date, issuance size, or broader reasons behind the market reaction, so the near-term effect is limited to a positive share-price response.